Temporal evolution of new T1-weighted hypo-intense lesions and central brain atrophy in patients with a first clinical demyelinating event treated with subcutaneous interferon β-1a.
Hugo VrenkenMarco BattagliniM L de VosG J NagtegaalBernardo Corrêa de Almeida TeixeiraAndrea SeitzingerDominic JackMaria Pia SormaniBernard M J UitdehaagA VersteegGiancarlo ComiLudwig KapposNicola De StefanoFrederik BarkhofPublished in: Journal of neurology (2023)
In patients with an FCDE, treatment with sc IFN β-1a tiw for 24 months reduced the number of new lesions evolving into black holes.